Eralp, Y <br/><br/>
MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Apr 2008 
 - 669-74 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdm522  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anthracyclines--pharmacology<br/>Antibiotics, Antineoplastic--pharmacology<br/>Biomarkers, Tumor--analysis<br/>Breast Neoplasms--chemistry<br/>Drug Resistance, Neoplasm<br/>ErbB Receptors--analysis<br/>Female<br/>Gene Expression Regulation, Enzymologic<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Immunohistochemistry<br/>Middle Aged<br/>Mitogen-Activated Protein Kinases--analysis<br/>Neoplasm Recurrence, Local--chemistry<br/>Odds Ratio<br/>Phosphatidylinositol 3-Kinases--analysis<br/>Prognosis<br/>Proportional Hazards Models<br/>Risk Assessment<br/>Risk Factors<br/>Up-Regulation